










































Since it is difficult to study what one cannot measure, 
the development of suitable measures of biological age 
has been a major goal of gerontology [1, 2]. Many 
biomarkers of aging have been studied ranging from 
telomere length [3, 4] to whole-body function such as 
gait speed. DNA methylation (DNAm) levels are 
particularly promising biomarkers of aging since 
chronological age (i.e. the calendar years that have 
passed since birth) has a profound effect on DNA 













































[5-14]. Several recent studies propose to measure 
accelerated aging effects using DNA methylation levels 
[15-20]. While previous epigenetic age predictors apply 
to a single tissue, our recently developed "epigenetic 
clock" (based on 353 dinucleotide markers known as 
Cytosine phosphate Guanines or CpGs) applies to most 
human cell types, tissues, and organs [19]. Predicted age, 
referred to as DNA methylation age, correlates with 
chronological age in sorted cell types (CD4 T cells, 
monocytes, B cells, glial cells, neurons), tissues and 
organs including whole blood, brain, breast, kidney, liver, 





























significantly over‐represented  (p=9.2x10‐9) among gene  transcripts  that are over‐expressed  in  the cerebellum compared  to
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lung, saliva [19], and even prenatal brain samples [21]. 
The epigenetic clock is an attractive biomarker of aging 
for the following reasons: a) it is more highly correlated 
with chronological age than previous biomarkers [22, 
23], b) it applies to most tissues, cell types, and fluids that 
contain human DNA (with the exception of sperm), c) it 
relates, to some extent, to biological age since DNAm 
age of blood is predictive of all-cause mortality even after 
adjusting for chronological age and a variety of known 
risk factors [24]. Similarly, markers of physical and 
mental fitness are also found to be associated with the 
epigenetic age of blood (lower abilities associated with 
age acceleration) [25]. Perhaps the most exciting feature 
of the epigenetic clock is the prospect of using it for 
comparing the ages of different tissues and cell types 
from the same individual [19]. While the mathematical 
algorithm lends itself for contrasting the ages of different 
tissues, it remains an open research question whether the 






































data for addressing this question, we proceed with all due 




We had previously shown that tissues from the same 
middle aged individuals exhibit similar DNAm ages 
[19] and additional data from the public domain confirm 
this result (Figure 1). But it is not yet known whether 
some tissues collected from centenarians - and 
particularly supercentenarians appear to be younger 
than the rest of the body, which would indicate that they 
are better protected against aging. Here we assess the 
epigenetic ages of an unprecedented number of tissues 
(up to 30 tissues) from supercentenarians and younger 
controls. An overview of our data sets is presented in 
Table 1. Apart from three novel DNA methylation data 




























































































Epigenetic age (referred to as DNAm age) was 
calculated as described in [19] from human samples 
profiled with the Illumina Infinium 450K platform. As 
expected, DNAm age has a strong linear relationship 
with chronological age in brain tissue samples (Figure 


















































mer's disease (AD) and age acceleration in these 
samples from older subjects, which is why we ignored 
disease status in the analysis. Strikingly, the DNAm age 
of cerebellar samples exhibits a lower rate of change with 
age than non-cerebellar samples (as can be seen by 
comparing the turquoise line with the red line in Figure 
Figure 2. Epigenetic age acceleration in various brain regions. (a) Scatter plot relating the DNAm age of each brain
sample (y‐axis) versus the corresponding chronological age (x‐axis).  Points are colored by brain regions (e.g. turquoise for
cerebellum)  as  indicated  in  (b‐h).  Linear  regression  lines  through  cerebellar  samples  and  non‐cerebellar  samples  are
colored in turquoise and red, respectively. Note that cerebellar samples (turquoise points) exhibit a lower rate of change
(i.e. slope of the turquoise line) than non‐cerebellar samples. In the scatter plots, circles and squares correspond to brain
regions  from Alzheimer's disease subjects and controls, respectively. Scatter plots show  (b) cerebellar samples only,  (c)
frontal  lobe,  (d) hippocampus,  (e) midbrain,  (f)  occipital  cortex,  (g)  temporal  cortex,  and  (h)  remaining brain  regions,
which  include caudate nucleus, cingulate gyrus, motor cortex,  sensory cortex and parietal cortex. The  subtitle of each
scatter plot reports a Pearson correlation coefficient and corresponding p‐value. Epigenetic age acceleration was defined
as  the vertical distance of each sample  from  the  red  regression  line  in  (a).  (i‐l) Age acceleration versus brain  region  in
different  age  groups  as  indicated  in  the  respective  titles.  Cerebellar  samples  tend  have  the  lowest  (negative)  age
acceleration  (turquoise  bars)  followed  by  occipital  cortex  (blue  bars).  Each  bar  plot  depicts  the mean  value  and  one
standard error and reports a non‐parametric group comparison test p‐value (Kruskal Wallis Test).  
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2a,b). To formally measure age acceleration effects, we 
defined age acceleration as the residual resulting from a 
linear model that regressed DNAm age against 
chronological age in non-cerebellar brain sample. Thus, 
a tissue sample that exhibits negative age acceleration 
appears to be younger than expected based simply on 
chronological age.  
 
All brain regions have similar DNAm ages in subjects 
younger than 80 (Figure 2i), but brain region becomes 
an increasingly significant determinant of age 
acceleration in older subjects (as can be seen from the 
Kruskal Wallis test p-values in Figure 2i-l).  
 
Note that the cerebellum and to a lesser extent the 
occipital cortex exhibit negative epigenetic age 
acceleration in the oldest old (Figure 2k), i.e. these brain 
regions are younger than expected. These results can 
also be observed by focusing on six individual 




































independent validation data sets (Figure 5). 
 
Comprehensive tissue analysis of a supercentenarian 
 
To study age acceleration effects in non-brain tissues as 
well, we profiled a total of 30 tissues of a 112 year old 
woman (Figure 3a) who is described in Methods. We 
generated at least 2 replicate measurements per tissue 
and found that replicate age estimates are highly 
reproducible (r=0.71, Figure 4). Interestingly, the 
cerebellum exhibited the lowest (negative) age 
acceleration effect compared to the remaining 29 other 
regions. In contrast, bone, bone marrow, and blood 
exhibit relatively older DNAm ages. Given that bone 
appears to be older than other parts of the body, it is 
worth mentioning that our novel data demonstrate that 
the epigenetic clock applies to bone samples (largely 
comprised of osteocytes/osteoblasts) as well (Figure 6). 
To understand why the cerebellum evades epigenetic 





































Figure  3.  Epigenetic  age  acceleration  in  tissues  from  individual  centenarians.  (a)  Mean  DNAm  age
























































































































Category Term DAVID GWAS 
MAGENTA 
CRBM 




nuclear lumen (GO:0031981) 202 2.5 6.0x10-35 1.6x10-3 











Biol. Process transcription (GO:0006350) 265 1.9 9.5x10-26 0.15 
mRNA processing (GO_0006397) 55 3.4 1.4x10-12 0.38 
chromatin modification (GO:0016568) 55 3.1 4.5x10-10 0.026 
Molecular F. 
RNA binding (GO:0003723) 93 1.9 7.1x10-7 0.040 
 helicase activity (GO:0004386) 31 3.3 8.5x10
-6 3.0x10-3 
INTERPRO DEAD-like helicase, N-terminal (IPR014001) 31 4.4 9.2x10-9 5.8x10-3 
808 under-expressed in cerebellum  
Biol. Process synaptic transmission (GO:0007268) 39 3.1 2.2x10-6 0.50 
neuron differentiation (GO:0030182) 49 2.7 2.4x10-6 0.030 
neuron projection development (GO:0010975) 19 6.5 9.6x10-7 0.54 
  Table 1. Overview of the DNA methylation datasets. The rows correspond to the datasets used  in this 
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Characterizing gene transcripts that are over/under 
expressed in cerebellum 
 
Using gene expression data from multiple brain regions 
of the Gibbs [26] data set (GSE15745), we identified 
1239 gene transcripts that were significantly over 
expressed in cerebellum compared to the pons, temporal 
cortex and frontal cortex from the same subjects at a 
false discovery rate (FDR) of 0.05. The results of a 
functional enrichment analysis with the “Database for 
Annotation, Visualization and Integrated Discovery” 
(DAVID, v6.7) [27] can be found in Table 1. The 1239 
over-expressed genes are highly enriched with genes 
that are located in the nucleus and are known to play a 
significant role in gene transcription, mRNA 

































































































(x‐axis). Linear  regression  lines  through cerebellar samples and non‐cerebellar samples are colored  in
turquoise and red, respectively. Note that cerebellar samples (turquoise points) tend to lie below non‐
cerebellar  samples.  (a)  Squares,  circles,  and  triangles  correspond  to  samples  from  controls, AD,  and




Figure  4.  Reproducibility  of  DNAm  age  in  the  112  year  old 
supercentenarian. For each of the 30 tissues of the supercente‐
narian, we  assessed  at  least  two  replicates  (two  independent 
DNA extractions for distant regions of the same tissue).  
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Thirty one of these over-expressed genes are involved in 
helicase activity (Bonferroni corrected p-value=8.5x10-6). 
RNA and DNA helicases are considered to be enzymes 
that catalyze the separation of double-stranded nucleic 
acids in an energy-dependent manner often coupled to 
ATP hydrolysis. However RNA helicases can function in 
other roles such as RNA folding, ribosome biogenesis, 
anchoring of substrates to form ribonucleoprotein 
complexes as well as disruption of RNA-protein 
complexes [28]. Helicases have been classified into six 
superfamilies (SF1-SF6)[29, 30]. We find that the two 
largest superfamilies (SF1 and SF2) are over-represented 
among the 1239 gene transcripts (p=9.2x10-9) with 
enrichment of genes with helicase or ATP binding 
domains including DEAD/DEAH box domains 
(IPR014001). Specifically when we considered genes 
listed on rnahelicase.org that are involved in pre-mRNA 
splicing (AQR, SNRNP200, DHX8, DHX15, DHX16, 
DHX38, EIF4A3, DDX39B, DDX3X, DDX3Y, DDX5, 
DDX23, DDX42 and DDX46), seven of these 14 (AQR, 
SNRNP200, DHX16, DHX38, DDX5, DDX42 and 
DDX46) are significantly overexpressed in cerebellum 






















Similarly, we identified 808 gene transcripts that were 
under-expressed in cerebellum at an FDR threshold of 
0.05. The top gene ontology categories among these 
under-expressed are specifically related to neuronal 
function and include neuron projection development, 
neuron differentiation, and synaptic transmission.  
 
Genetic enrichment analysis 
 
To determine which of the cerebellum associated 
transcriptional differences might play a causal role in 
keeping the cerebellum young, we tested whether the 
gene categories from Table 2 show enrichment for 
SNPs that relate to epigenetic age acceleration in 
cerebellum. The MAGENTA approach [31] was used to 
test whether the sets of functionally related genes in 
Table 2 are enriched for SNP associations with 
epigenetic age acceleration in cerebellar samples. 
Toward this end, we applied MAGENTA to results 
from our GWAS meta-analysis of epigenetic 
acceleration in cerebellum (Methods). The meta 
analysis was based on four independent data sets for 
which both SNP data and cerebellar DNA methylation 
data were measured on the same subjects (n = 354, see 
Methods). The MAGENTA results can be found in the 
last column of Table 2. Even after adjusting for multiple 
comparisons, significant enrichment results can be 
observed for the GO category "nuclear lumen" 
(p=0.0016), and the molecular function "helicase 
activity" (p=0.0030). Helicase superfamilies SF1 and 
SF2 (particularly SF2) are highly enriched (p = 5.8x10-
3) based on SNPs associated with the following genes 
DHX57, CHD8, DHX15, DDX19A, DDX19B, DDX2, 
BLM, SMARCA5, SNORA67, EIF4A1, HLTF, 
C9orf102. Interestingly, another DEAD box related 
gene, DHX16, was the most significantly (q-
value=1.5x10-5) over-expressed gene in cerebellum 
compared to other brain regions but it was not 




While our study of a supercentenarian suggests that the 
epigenetic age of cerebellar tissue is younger than other 
part of the body we need to highlight several caveats. 
Although the epigenetic clock lends itself for comparing 
the epigenetic ages of multiple tissues, it remains to be 
seen whether the difference between nervous and non-
nervous tissue reflects differences in biological aging 
rates. We are on safer ground when it comes to 
comparing the ages of different brain regions. We are 
confident in the finding that the cerebellum has a lower 
epigenetic age than other brain regions in older subjects 
since this effect could be observed in three independent 
data sets and 6 individual centenarians. This finding 
raises several questions. The most pressing question is 
whether this implies that the cerebellum is biologically 
younger  than other brain regions? While the epigenetic 
age of blood has been shown to relate to biological age 
[24, 25], the same cannot yet been said about brain 
tissue. As a matter of fact, our study provides the first 
admittedly indirect and circumstantial evidence that the 
epigenetic age of brain tissue relates to biological age 
because the cerebellum exhibits fewer neuro-
pathological hallmarks of age related dementias 
compared to other brain regions. But prospective studies 
Figure 6. DNAm age  (y‐axis) versus age  (x‐axis)  in bone
(osteocytes/osteoblasts).  The  blue  dots  corresponds  to  the
samples  in data  set 3  (bone). The  red dots  corresponds  to  the
replicate bone samples from the 112 year old super centenarian. 
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in model organisms will be needed to show that the 
epigenetic age of brain tissue predicts the future onset 
of age related diseases even after correcting for 
chronological age and known risk factors. Another open 
question is why does the cerebellum have a slower 
aging rate? In an attempt to address this question, we 
used both transcriptional and genetic data. We found 
several gene ontology categories that are enriched in 
genes that are over-expressed in the cerebellum 
(including helicases). But the results from our 
differential expression analysis must be interpreted with 
caution for two reasons. First, cellular heterogeneity 
may confound these results since the cerebellum 
involves distinct cell types. Second, this cross-sectional 
analysis does not lend itself for dissecting cause and 
effect relationships. To partially address these concerns, 
we used genetic data. It is striking that SNPs that relate 
to the epigenetic age acceleration of the cerebellum also 
tend to be located near RNA helicase genes as observed 
in our transcriptional data. These results suggest that 
RNA helicase genes might play a role in slowing down 
the epigenetic age of the cerebellum. Unfortunately, 
RNA helicase genes are not a "smoking gun" for any 
particular molecular process. RNA helicases are 
ubiquitous and essential proteins for most processes of 
RNA metabolism (e.g. ribosome biogenesis, pre-mRNA 
splicing, translation initiation) and also function as 
regulators of gene expression by non-coding RNAs, 
detection of specific RNA molecules, sensing of small 
compounds or transduction of metabolic signals [32]. 
Although we could not find any prior literature on the 
role of RNA helicases in tissue aging, the same cannot be 
said for DNA helicases: e.g. WRN, which is a member of 
the RecQ helicase family, is implicated in Werner's 
syndrome, which is a recessively inherited progeria.  
 
The interpretation of our main finding (regarding the 
epigenetic age of the cerebellum) is also complicated by 
the fact that we still don't know what is being measured 
by epigenetic age. While many articles suggest that age-
related changes in DNAm levels represent random noise 
others suggest that there might be a purposeful 
biological mechanism [33-35]. DNAm age might 
measure the cumulative work of an Epigenomic 
Maintenance System (EMS) [19]. Under the EMS 
hypothesis, our findings suggest that cerebellar DNA is 
epigenetically more stable and requires less 
"maintenance work". But many other explanations 
could explain our findings including the following: a) 
the cerebellum has a lower metabolic rate than cortex 
[36-38], b) it has far fewer mitochondrial DNA 
(mtDNA) deletions than cortex especially in older 
subjects [39], and it accumulates less oxidative damage 
to both mtDNA and nuclear DNA than does cortex [40].  
In conclusion, this is probably the first study to show 
that the cerebellum ages more slowly than other brain 
regions and possibly many other parts of the body. By 
understanding why the cerebellum is protected against 
aging, it might be possible to understand the cause of 





Description of datasets listed in Table 1. All data 
presented in this article have been made publicly 
available in public repositories. Gene Expression 
Omnibus accession numbers are presented in Table 1.  
 
Data set 1: Bisulphite converted DNA from these 
samples were hybridized to the Illumina Infinium 450K 
Human Methylation Beadchip. 260 arrays were 
generated from 39 subjects (19 females). Twenty-one 
subjects presented with Alzheimer's Disease (AD) 
whereas 18 subjects did not have any neurodegenerative 
disease. None of the subjects had brain malignancies. 
After adjusting for chronological age, we could not 
detect an age acceleration effect due to AD status, 
which is why we ignored AD status in the analysis. We 
profiled the following brain regions: caudate nucleus (n 
= 12 arrays), cingulate gyrus (n=12 arrays), cerebellum 
(32), hippocampus (25), inferior parietal cortex (11), 
left frontal lobe (9), left occipital cortex (12), left 
temporal cortex (18), midbrain (18), middle frontal 
gyrus (12), motor cortex (12), right frontal lobe (20), 
right occipital cortex (21), right temporal cortex (11), 
sensory cortex (12), superior parietal cortex (12), and 
visual cortex (11). 
Data set 2: Multiple tissues from a 112 year old, female 
supercentenarian. 64 arrays were generated from 30 
tissues/regions (listed in Figure 3). 
Data set 3: Novel bone data set. The trabecular bone 
pieces were obtained from the central part of the 
femoral head of Spanish (Caucasian) patients with hip 
fractures (due to osteoporosis) or subjects with 
osteoarthritis. Since osteoarthritis status was not related 
to DNA methylation age, we ignored it in the analysis. 
Data set 4: Multiple tissues (listed in Figure 1) from 
GEO: GSE50192 [41]. 
Data set 5: Various brain regions and whole blood from 
(GEO data GSE59685) [42].  
Specifically, the following tissues were available: 
entorhinal cortex, cerebellum, frontal cortex, superior 
temporal gyrus, and whole blood.  
Data set 6: Pre-frontal cortex and cerebellum samples 
from schizophrenics and controls (GEO data 
GSE61431) [43].  
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Disease status could be ignored in data sets 5 and 6 
because our tissue comparisons involved samples from 
the same subjects. Our results were qualitatively the 
same after using a multivariate regression model that 
accounted for disease status. 
 
DNA extraction. AllPrep DNA/RNA/miRNA Universal 
Kit (Qiagen, cat # 80224) was used for the DNA 
extractions for frozen tissue samples. Cubes 3x3x3mm 
with approximate mass of ~30 mg were cut from 
histological specimens collected during necropsies. 
Bone was dissected into bone and bone marrow 
(3x3x3mm each specimen) and separated into 2 
different microcentrifuge tubes for DNA extractions. 
The procedure was conducted on dry ice without 
thawing the samples down to preserve RNA quality for 
prospective studies. 30mg of frozen tissue was lysed 
with 600uL guanidine-isothiocyanate–containing Buffer 
RLT Plus in a 2.0mL microcentrifuge tube, and 
homogenized by using TissueLyser II (Qiagen) with 
5mm stainless steel beads. Tissue lysate was continued 
with the AllPrep protocol for simultaneous extraction of 
genomic DNA and total RNA using RNeasy Mini spin 
column technology. DNA yields were on average 16ug, 
with the highest yield from Spleen tissue (46 ug) and 
the lowest yield from Adipose tissue (2.2 ug). 
 
We did not use bone specimens where we could 
macroscopically see both solid bone and bone marrow, 
so we did not use any additional washing steps to 
remove bone marrow. 
 
Preprocessing of Illumina Infinium 450K arrays. In 
brief, bisulfite conversion using the Zymo EZ DNA 
Methylation Kit (ZymoResearch, Orange, CA, USA) as 
well as subsequent hybridization of the 
HumanMethylation450k Bead Chip (Illumina, 
SanDiego, CA), and scanning (iScan, Illumina) were 
performed according to the manufacturers protocols by 
applying standard settings. DNA methylation levels (β 
values) were determined by calculating the ratio of 
intensities between methylated (signal A) and un-
methylated (signal B) sites. Specifically, the β value 
was calculated from the intensity of the methylated (M 
corresponding to signal A) and un-methylated (U 
corresponding to signal B) sites, as the ratio of 
fluorescent signals β = Max(M,0)/[Max(M,0)+Max(U,0) 
+100]. Thus, β values range from 0 (completely un-
methylated) to 1 (completely methylated) [44].  
 
Many authors have described methods for dealing with 
the two types of probes found on the Illumina 450k 
array [45-47]. This is not a concern for the epigenetic 
clock since it mainly involves type II probes. But our 
software implements a data normalization step that 
repurposes the BMIQ normalization method from 
Teschendorff [46] so that it automatically references 
each sample to a gold standard based on type II probes 
(details can be found in Additional file 2 from [19]). 
 
DNA methylation age and epigenetic clock. Many 
articles describe sets of CpGs that correlate with age in 
multiple tissues [5, 7, 8, 14, 48-50]. Although these 
reports firmly establish the strong effect of age on 
epigenetic modifications, individual CpG sites are 
unsuitable for global contrasting of the epigenetic ages 
of different tissues derived from the same individual. 
Epigenetic age was calculated as reported previously. 
The epigenetic clock is defined as a prediction method 
of age based on the DNAm levels of 353 CpGs. 
Predicted age, referred to as DNAm age, correlates with 
chronological age in sorted cell types (CD4 T cells, 
monocytes, B cells, glial cells, neurons) and tissues and 
organs including whole blood, brain, breast, kidney, 
liver, lung, saliva [19]. Mathematical details and 
software tutorials for the epigenetic clock can be found 
in the Additional files of [19]. An online age calculator 
can be found at our webpage 
(https://dnamage.genetics.ucla.edu). 
 
Finding gene transcripts that were differentially 
expressed in cerebellum compared to three other brain 
regions. The data set from Gibbs et al [26] also 
contained gene expression data from the brain regions 
of the same subjects for whom DNA methylation data 
were available. We used these data to find genes that 
were over-expressed in cerebellum compared to the 
pons, temporal cortex, and frontal cortex. 
 
Since multiple brain regions were available for each 
subject, we used a paired T test to find genes that were 
differentially expressed between a) cerebellum and 
pons, b) cerebellum and temporal cortex, and c) 
cerebellum and frontal cortex. The matched design (3 
brain regions from the same subjects) allowed us to 
condition out chronological age, ethnicity, gender, and 
other subject level confounders. For each of the three 
matched pairwise comparisons, we obtained a T-
statistic based on the differences in expression values. 
Next we combined the resulting three T statistics using 
a conservative meta analysis approach: the scaled 
Stouffer method implemented in the "rankPvalue" R 
function [51, 52]. The resulting meta analysis p-values 
were transformed to local false discovery rates (q-
values) using the qvalue R package [53]. At a 1-sided 
false discovery rate (FDR) threshold (qValueHighScale) 
of 0.05 we found 1239 Illumina probes that were over-
expressed in cerebellum. Details on these and all other 
probes on the Illumina array can be found in 
Supplementary Table S1 (MarginalAnalysisGibbsMeta). 
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Similarly we identified 808 gene transcripts that were 
significantly under-expressed in cerebellum at a FDR 
threshold of 0.05. 
 
The results of a functional enrichment analysis with the 
“Database for Annotation, Visualization and Integrated 
Discovery” (DAVID, v6.7) [27] applied to the 1239 
overexpressed and the 808 underexpressed genes can be 
found in Supplementary Table S2 (DavidEASEQ05over. 
xlsx) and Supplementary table S3 (DavidEASEQ05 
under.xlsx), respectively. 
 
Also our functional enrichment analysis results using 
DAVID are qualitatively unchanged when other FDR 
thresholds (e.g. 0.01) are used. 
 
MAGENTA analysis for GWAS enrichment. 
MAGENTA is a computational tool that tests for 
enrichment of genetic associations in predefined 
biological processes or sets of functionally related 
genes, using genome-wide association results as input 
[31]. MAGENTA is designed to analyze datasets for 
which genotype data are not readily available, such as 
large genome-wide association study (GWAS) meta-
analyses. As input of MAGENTA, we used the results 
of a genome-wide meta-analysis for epigenetic age 
acceleration in human cerebellum. In total, this analysis 
involved cerebellar DNA methylation data and SNP 
data from 354 Caucasian subjects from the following 
independent studies: 59 Caucasian individuals from a 
study for Alzheimer’s disease [42], 112 neurologically 
normal samples from [26], 147 samples from a case 
control of psychiatric disorders [54], and 36 Caucasian 
samples from a case control study of schizophrenia 
[43]. We ignored disease status in our GWAS analysis 
since it had a negligible effect on age acceleration in 
cerebellum (t-test P > 0.1). Caucasian ethnicity was 
verified in PLINK or EIGENSTRAT[55].  
 
Age acceleration outcome measure was defined in the 
same way that we utilized the residuals from regression 
of DNAm age on chronological age. Quantitative trait 
association analysis was performed on each study, 
adjusted for principal components when necessary. 
Fixed-effects models weighted by inverse variance [56] 
were applied to combine the association results across 
studies, yielding a total of 4,586,301 association P 
values as the input for the MAGENTA analysis. We 
extended the gene boundary with +/- 50 kilobases to 
assign SNPs to their nearby genes and selected the 
GSEA (Genome Set Enrichment Analysis) method with 
cutoff set at 95th percentile to estimate enrichment P 
values starting with 10,000 permutations then increased 
to 100,000 for P < 1.0x10-4. 
Brief Information of the 112 year old. The likely cause  
of death was bilateral organizing pneumonia. 
Neuropathologic findings were those of Alzheimer's 
disease, Braak stage IV-V, NIA-AA stage A2B2C2 
[57]. Neuritic plaques were abundant in hippocampus, 
frontal cortex and temporal cortex and less prominant in 
basal ganglia and occipital cortex. Neurofibrillary 
tangles were abundant in hippocampus and sparse in 
frontal and temporal cortices.  
 
Ethics review and IRB. All subjects from the UCLA 
tissue bank signed the "Consent for Autopsy" form by 
the Department of Pathology at UCLA, and research 
procurement was performed under IRB Research 
Protocol Number 11-002504. Further, the epigenetic 
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